https://www.prophecymarketinsights.com/market_insight/Global-Sandhoff-Disease-Treatment-Market-4724
Global Sandhoff Disease Treatment Market Sandhoff disease is a lysosomal storage disorder that is extremely rare. Nerve cells are destroyed as a result of it (neurodegeneration). This causes issues with thinking and movement. Sandhoff disease, also known as Beta-hexosaminidase-beta-subunit deficiency, is a fatal lysosomal storage genetic illness in children that causes progressive neuron loss in the brain and spinal cord. As a result of accumulation of fat termed G2 gangliosides, it is caused by abnormalities in the HEXB gene, which is important for the regulation of a critical enzyme called beta-hexosaminidase.
0 condivisioni